Core Points - The Gross Law Firm has issued a notice to shareholders of Replimune Group, Inc. regarding a class action lawsuit related to misleading statements made by the company during the class period from November 22, 2024, to July 21, 2025 [1] - Allegations include that Replimune Group overstated the prospects of the IGNYTE trial, which the FDA deemed inadequate and not well-controlled, leading to materially false and misleading statements about the company's business and operations [1] - Shareholders are encouraged to register for the class action by September 22, 2025, to potentially be appointed as lead plaintiffs and to receive updates on the case [2] Company Information - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit, fraud, and illegal business practices [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3]
Contact The Gross Law Firm by September 22, 2025 Deadline to Join Class Action Against Replimune Group, Inc.(REPL)